Friday, December 31, 2010
There are many cord blood banks, all offering similar services. So how do you choose? http://ping.fm/zG6XA
Compare Cryo-Cell’s industry-leading quality, impeccable client service, exclusive features http://ping.fm/Yqi4H
Welcome 2011 and your new baby too! Because we believe that there is nothing more important than protecting your baby's future
http://ping.fm/7DSbH
http://ping.fm/7DSbH
Thursday, December 30, 2010
Stem cell collection, processing & preservation:
a once-in-a-lifetime opportunity. http://ping.fm/7nuTF
a once-in-a-lifetime opportunity. http://ping.fm/7nuTF
Wednesday, December 29, 2010
Cryo-Cell is the most established family cord blood banks and the industry's quality leader. http://ping.fm/TprqC
Save up to 20% + FREE baby Bjorn carrier at Cryo-cell http://www.cryo-cell.com/current_offers/current_offer.asp
Today’s challenging economic times make us want to show our loved ones we care for more http://ping.fm/oTNND
Cryo-Cell International Responds to Announcement of Intent to Acquire One of the Company’s Global License Affiliates http://ping.fm/ypDcM
Tuesday, December 28, 2010
watch reports about stem cell research from local news networks, or learn more about cord blood banking from Cryo-Cell. http://ping.fm/q8jgh
In order to provide the Cryo-Cell U-Cord® Stem Cell Preservation Service abroad,around the world. Currently http://tinyurl.com/35ne8oa
o-Cell International, Inc., proudly introduces Cryology Reproductive Tissue Storage for more
http://ping.fm/Alz99
http://ping.fm/Alz99
Thursday, December 23, 2010
CRYO-CELL INTERNATIONAL RESPONDS TO ANNOUNCEMENT OF INTENT TO ACQUIRE ONE OF THE COMPANY’S GLOBAL LICENSE AFFILIATES
http://ping.fm/HVoe3
http://ping.fm/HVoe3
Cryo-Cell’s credentials and felt comfortable making the decision to store and preserve one son’s future.
http://ping.fm/OTyZ1
http://ping.fm/OTyZ1
The decision to store our baby’s cord blood was confirmed when our obstetrician
http://ping.fm/3LEsG
http://ping.fm/3LEsG
In this event, a Cryo-Cell Transportation Coordinator will assist you with scheduling http://ping.fm/yfH39
Cryo-Cell's industry-exclusive agreement with Upromise® offers clients 2% of all fees as cash back for college. http://cryo-cell.com/testimonials/testimonial_16.asp
We are planning on having one more baby and will do the same with his or her blood. http://ping.fm/BvjLw
We employ only qualified personnel, and use the best and most advanced equipment
http://ping.fm/jlQxU
http://ping.fm/jlQxU
We chose Cryo-Cell because of their locked-in pricing, great customer service and college savings!
http://ping.fm/lY9AI
http://ping.fm/lY9AI
Cryo-Cell is the only cord blood bank in the world to offer this exclusive ground-breaking
http://ping.fm/zDvsS
http://ping.fm/zDvsS
Cryo-Cell is on the forefront of medical research and development with globally-renowned
http://ping.fm/ougaf
http://ping.fm/ougaf
Wednesday, December 22, 2010
Tuesday, December 21, 2010
Monday, December 20, 2010
We believe that Cryo-Cell’s premium quality, differentiated features and competitive price say it all… You be the judge! http://ping.fm/kmwY9
Compare Cryo-Cell’s industry-leading quality, impeccable client service, exclusive features and many more http://ping.fm/UICBp
First, cord blood stem cells are easily extracted, resulting in no risk or pain for the mother or baby. for more http://ping.fm/4pVj3
Recently it has been discovered that the stem cells have the power to regenerate. http://ping.fm/7LaQN
Saturday, December 18, 2010
We try to tell anyone who is expecting about cord blood banking and info on Cryo-Cell. http://ping.fm/LWHLT
It was an interesting experience, and now our family recommends Cryo-Cell to everyone they know that’s having a baby.http://ping.fm/3B16z
Friday, December 17, 2010
Thursday, December 16, 2010
cord blood storage and cord blood preservation at our private cord blood bank facility. http://ping.fm/RtBS4
Learn more about our U-Cord® Service and our Plureon® Placental Stem Cell Service. http://ping.fm/BgAcm
Cryo-Cell offers cord blood collection, cord blood storage and cord blood preservation at our private cord blood bank facility. http://ping.fm/LbHcp
Cryo-Cell Cord Blood Bank is pioneering the way in research, to find more solutions to preserve stem cells for more http://ping.fm/KHJVG
Stem cell research controversy,The largest family cord blood bank, Cryo-Cell offers cord blood collection:http://tinyurl.com/37v4fvw
cord blood storage and cord blood preservation at our private cord blood bank facility for more details visit:http://tinyurl.com/29vxmqy
We provide cord blood services dat include cord blood collection and preservation for more visit:http://tinyurl.com/36z2nfo
The largest family cord blood bank, Cryo-Cell offers cord blood collection for more:http://tinyurl.com/38ygvfh
Wednesday, December 15, 2010
Bank your New Born’s Umbilical Cord Blood with Cryo-Cell International for more http://ping.fm/HGrph
Few modern researchers have proved that even if the process is a little expensive still parents should always be encouraged to preserve the cord blood for future. http://ping.fm/NzLhy
Tuesday, December 14, 2010
Cryo-Cell wants to help your family safeguard future health. This is a limited-time offer, so don't wait for more http://ping.fm/2jN0u
Today’s challenging economic times make us want to show our loved ones we care for more http://ping.fm/9jBuB
preserve their newborn's umbilical cord blood for potential use against many diseases. Along with cord blood banking, Cryo-Cell Cord Blood Bank is pioneering the way in research for more http://ping.fm/HyIuI
Wednesday, August 25, 2010
Cord Blood Banking Process - Cryo-Cell
Cord Blood Banking Process - Cryo-Cell
The Cord Blood Banking Process
Stem cell collection, processing & preservation:
a once-in-a-lifetime opportunity.
For most parents, the process of collecting, processing and preserving their newborn’s cord blood is a new one. The more you learn about cord blood banking, the more you’ll realize how simple it is to do. Below is valuable information about banking your baby’s cord blood. Should you still have any questions, our highly trained nurses are available 24 hours a day, 7 days a week.
Cord Blood Collection
Cord blood is collected from the umbilical cord immediately after a baby’s birth, but generally before the placenta has been delivered. The moment of delivery is the only opportunity to harvest a newborn’s stem cells. There is absolutely no pain or risk to the mother or child during the collection process since the blood is taken from the cord once it has been clamped and cut. And collection is safe for both vaginal and cesarean deliveries.
To collect cord blood, a healthcare provider uses a U-Cord® Collection Kit supplied by Cryo-Cell Cord Blood Bank —so advance arrangements will need to be made. Cord blood is drawn from the umbilical cord into the blood collection bag that comes in the kit. The mother’s blood will also be collected at this time, to be tested for certain infectious diseases required by regulations. Both the baby’s and mother’s blood are then packaged in the special shipping materials provided. Lastly, parents call a courier's toll-free telephone number to arrange for pick-up and delivery of the cord blood to Cryo-Cell’s laboratory.
Many healthcare professionals charge a fee for the procedure of collecting umbilical cord blood. So, discuss this procedure with them prior to enrolling in our service to verify their agreement to perform the collection. Cryo-Cell’s clients have the opportunity to be reimbursed up to $175 by Cryo-Cell Cord Blood Bank for professional collection fees, when presented with proper documentation. This reimbursement will be credited to your Cryo-Cell account or paid directly to your caregiver's practice. A form is provided with the collection kit.
Cord Blood Processing
Within 36 to 48 hours of collection, the blood is processed, tested, separated and its stem cells cryogenically stored (frozen). But the process is by no means simple.
First, an affiliated laboratory that is CLIA-certified and FDA-registered tests the mother’s blood for syphilis, hepatitis, HTLV, HIV and CMV. This testing regimen determines the infectious disease status, and allows the cord blood to potentially be used for family use, not just autologous (self) use. In the event that any of the infectious disease screening tests are positive, confirmatory tests will be automatically performed. The cost for initial screening tests is included in your enrollment fee. Should confirmatory testing be required it will be billed separately and will typically cost less than $100.00. Each cord blood sample is also tested to confirm the absence of microbiological contamination.
Then, Cryo-Cell Cord Blood Bank utilizes a hydroxyethyl starch (Hespan®) method to reduce the number of red blood cells, isolating the nucleated white blood cell fraction, which contains the stem cells. These cells are then mixed with DMSO, the cryoprotectant, and Dextran, and stored in a special, compartmentalized cryobag. Simply put, Cryo-Cell Cord Blood Bank uses a medically proven, scientifically advanced process to prepare your newborn’s stem cells for storage.
Note that human tissue (HLA) typing is not routinely performe
d at the time of processing, but would be necessary to confirm compatibility if the stem cells are being considered for use in treatment where the recipient is not also the donor. HLA typing may be performed via blood testing as an insurance-reimbursable cost in a typical physician-ordered transplant work-up.
Cryogenic Cord Blood Storage
To store our clients’ precious stem cells, Cryo-Cell Cord Blood Bank uses special, compartmentalized cryobags. The bag includes a 20ml and 5ml sample and three segments for testing, and is over-wrapped for added protection. A technique called "controlled-rate freezing" is used to prepare the cells for long-term storage. Then the bag is housed in a protective cassette and placed in liquid nitrogen dewars for cryogenic (frozen) preservation. Our storage conditions are closely monitored for security and temperature. Once the stem cells are stored, the parents, as the child’s guardians, have control over their use and disposal. Initially, no stem cells will be released by Cryo-Cell Cord Blood Bank without the parents' consent. Once the child reaches legal age, however, control passes to him or her.
It is believed that stem cells can be successfully stored long term, perhaps decades, in a cryopreserved form, though sufficient years have not passed to prove the absolute length of time. However, a recent study of cord blood at Indiana University demonstrated its viability after 15 years of cryogenic storage. What’s more, bone marrow has been stored for decades and has remained viable—there is no reason to believe that the same would not be true of cord blood.
Cord blood and Placental Stem Cells - Cryo-Cell
Cord blood and Placental Stem Cells - Cryo-Cell:
Stem Cell Research News
Recent News
Cryo-Cell Announces Progress with Strategic Partner S-Evans Biosciences, Inc.
8/23/2010
Célle(SM) Menstrual Stem Cell Technology License Partner Opens State-of-the-Art Laboratory and Research & Development Facility in China
Cryo-Cell Announces Célle(SM) Research And Development Collaboration With Department Of Medicine, Monash University
8/17/2010
Australian-Based Researchers to Explore Potential of Menstrual Blood Stem Cells to Treat Autoimmune Disease
Cryo-Cell Resports Results for Fiscal 2009
3/1/2010
Company Reports Profitable Fiscal 2009 With Net Income of $1.4 Million
Cryo-Cell CEO Mercedes Walton Invites Women to Share Their Ideas on Self-Care and the Power of Stem Cells
12/30/2009
Free C’elle collection and 20 year storage to be awarded to one video entrant through its “Resolution Revolution” New Year’s promotion
New Hampshire Family Counts Blessings after Stem Cell Treatment
12/29/2009
Umbilical Cord Stem Cell Therapy Treats Young Mother’s Aplastic Anemia
Vitamin C Could Help With Creating Non-Controversial Adult Stem Cells
12/24/2009
Research suggests the vitamin helps reprogramming of adult stem cells to become induced pluripotent stem cells (iPSCs)
German Center Treats 2,000th Stem Cell Patient
12/21/2009
XCell-Center in Dusseldorf specializes in autologous stem cell treatments
Induced Pluripotent Stem Cells Named Decade’s Most Important Biomedical Discovery
12/18/2009
MIT Professor Explains how iPS cells opened new avenues for possible treatment of diseases such as Parkinson’s Disease and type 1 diabetes
Stem Cell Treatment Enables MS Patient to Walk Again
12/14/2009
Australian physicians used stem cells to “reset” the patient’s immune system
Lone Star Paralysis Foundation to Study Use of Umbilical Cord Blood Stem Cells
12/14/2009
Research study led by Dr. Wise Young of Rutgers will study how stem cell treatments using cord blood could be used to cure spinal cord injuries
Hospital Group in India to Treat Diabetes with Cord Blood Stem Cells
12/13/2009
Global Hospitals expects to start treating patients with type 1 diabetes by June 2010
Company Develops Technology to Improve Engraftment Following Cord Blood Transplants
12/8/2009
Researchers from Duke University and Aldagen, Inc. Report at American Society of Hematology’s Annual Meeting
Umbilical Cord Blood Stem Cell Transplant May Help Lung, Heart Disorders
11/24/2009
Scientists confirm that studies add to the potential uses for cord blood stem cells
Stem Cell Transplant Success Story: The Kumar Family
11/18/2009
Thanks to a transplant of stem cells from her brother’s umbilical cord blood, eight-year-old Thamirabharuni Kumar is beating thalassemia.
Heart Therapy with Stem Cells Shows Progress
11/18/2009
Northwestern University researcher rebuilding weak hearts
Bill Would Educate Parents on Umbilical Cord Blood
11/18/2009
“Informed Choice” legislation would require doctors to give expectant parents information about collecting and banking cord blood stem cells
Texas Man Says Stem Cell Treatment Saved His Life
11/17/2009
Texas man reports improvements after autologous stem cell treatment in Thailand for heart failure; more than 200 scientific trials underway in U.S. for stem cell treatments for heart disease.
Stem Cells Improve Heart Function in Patients with Cardiomyopathy
11/16/2009
Cardiologist is using stem cell therapy sees “extraordinary” results
“Adult Stem Cells Saved My Life” Campaign Set to Launch
11/12/2009
Family Research Council shares stories of successful stem cell transplant patients
Market Experts Report Aggressive Growth in Stem Cells Market Driven by “Enormous Potential of Stem Cells”
11/7/2009
Increasing demand for stem cell treatments including regenerative medicine and drug discovery
Stem Cell Study Underway at Baptist Hospital
11/6/2009
Phase II clinical study involving stem cell treatment for cardiovascular disease is underway
Increasing the Number of Stem Cells Derived from Umbilical Cord Blood Provides Alternative to Bone Marrow Transplantation in Adults
11/2/2009
Investigational Product Shown to Expand Population of Umbilical Cord Blood Stem Cells for Treatment of Leukemia and Lymphoma
Renowned Scientists in Collaboration to Research and Develop Induced Pluripotent Stem (IPS) Cells for Cardiac Therapies
11/1/2009
National Heart Lung and Blood Institute funds multi-year, multimillion dollar project to focus on stem and progenitor cell tools and treatments
California Stem Cell Agency Awards $230 Million Research Grants
10/29/2009
Funding will support stem cell research into treating cancer, diabetes and a host of other devastating diseases that scientists hope will be ready to test in human subjects in the next four years.
UCLA Stem Cell Scientists Receive $49.2 Million to Develop New Therapies for Disease
10/28/2009
California Institute for Regenerative Medicine awards grants to fast-track development of stem cell-based treatments for diseases including sickle cell disease, HIV/AIDS and brain, ovarian and colorectal cancers.
Professional Soccer Player’s Wife in Remission after Cord Blood Stem Cell Treatment for Leukemia
10/28/2009
Real Salt Lake Midfielder’s Andy Williams’ Improved Performance Coincides with His Wife’s Improved Health
Updated NCCN Guidelines for Treatment of Acute Myeloid Leukemia Include Cord Blood Stem Cells
10/19/2009
The National Comprehensive Cancer Network (NCCN) announced updates to the Clinical Practice Guidelines in Oncology(TM) for Acute Myeloid Leukemia (AML) to include cord blood as an official stem cell treatment option.
John Daly After Stem Cell Treatment - “Miraculous Recovery”
10/14/2009
The PGA of Australia reports in a statement that, “thanks to a miraculous recovery, American crowd favorite and dual Major winner John Daly will return to Australia in December to play the 2009 Australian Open and the Australian PGA Championship…”
Cryo-Cell International’s Stem Cell Research and Development Helps the Fight Against Breast Cancer
10/6/2009
Ongoing Initiatives Include Research Partnership with National Institutes of Health to Study C’elle Menstrual Blood Stem Cells
Congress Encouraged to Continue Senator Kennedy’s Legacy of Supporting Stem Cell Research & Development
9/29/2009
Cryo-Cell Inc. CEO Mercedes Walton Hopeful that Momentum on Stem Cell Initiatives Will Continue
Children’s Hospital of Colorado Participating in Trial Using Therapy Derived from Cord Blood Stem Cells To Treat Leukemia and Lymphoma
9/16/2009
Children’s Hospital of Colorado enrolling patients for a cord blood stem cell transplant study
Cord Blood Stem Cells Used to Treat Paralysis
9/14/2009
A Texas-based organization reports that it will raise $3 million to help fund the first non-controversial stem cell trials for people with Spinal Cord Injury.
Umbilical Cord Stem Cells Treat Boy with Cerebral Palsy
9/12/2009
Stem cell treatment helps boy with cerebral palsy
California's Stem Cell Agency Awards $5.42 Million to UCLA Researchers
9/10/2009
The California Institute of Regenerative Medicine (CIRM) has awarded a total of $5.42 million in stem cell grants to four scientists at UCLA's Broad Stem Cell Research Center.
Renowned Doctor Announces Change of View Regarding Private Cord Blood Banking, saying “If they can afford it, people should store their baby’s blood”
9/3/2009
Neuroscientist outlines reasons for changing his position regarding the importance of storing stem cells from cord blood
Harvard University Launches First Undergrad Degree Concentrating on Stem Cells
9/3/2009
Harvard University’s Department of Stem Cell and Regenerative Biology (SCRB) has introduced a new field of study as a concentration to its undergraduate students, called human development and regenerative biology (HDRB).
Ohio Senate to Vote on Cord Blood Awareness Legislation
9/1/2009
Proposed legislation promoting awareness for benefits of cord blood storage has bipartisan support
Doctors Take Up Collection to Pay for Patient’s Umbilical Cord Blood Banking
8/25/2009
Cincinnati doctors pay to bank stem cells from baby's cord blood.
Stem Cells Used to Grow Tooth in the Mouth of a Mouse
8/10/2009
The Wall Street Journal’s Jeremy Singer-Vine reports that researchers at the Tokyo University of Science have used stem cells to grow a replacement tooth for a mouse. A report in the Proceedings of the National Academy of Sciences reports that this is the first time that scientists have developed a fully functioning three-dimensional organ replacement using stem cells. The scientists created a set of cells that contained genetic instructions to build a tooth, and then implanted it into the mouse’s tooth socket. The tooth grew in the same manner that a natural one would. After 11 weeks, it had a similar shape, hardness and response to pain or stress as a natural tooth, and worked equally well for chewing. The researchers suggested that using similar techniques in humans could restore function to patients with organ failure.
Adult Stem Cells Help Ease Arthritis
8/7/2009
Dr. Max Gomez of WCBS TV reports on a clinic near Denver, Colorado that is using adult stem cells to treat osteo-arthritis of the knee, hip, ankle, and even back pain. Dr. Christopher Centeno and two of his patients discuss the process and their experience.
Fallopian Tubes a Source of Stem Cells
8/7/2009
BBC News reports that researchers in Sao Paulo, Brazil have discovered that fallopian tubes are an abundant source of mesenchymal stem cells. Because fallopian tubes normally are discarded during surgeries such as hysterectomies, they may be good source for non-controversial donor cells for regenerative medicine. In addition, the researchers anticipate that the cells could be useful for understanding and treating fertility problems. The researchers’ findings were published in the Journal of Transitional Medicine.
Scientists Use Adult Stem Cells to Create Healthy Mice
8/7/2009
Alan Mozes of BusinessWeek’s HealthDay reports on a milestone in stem cell research. Chinese scientists have grown healthy, fertile mice by using pluripotent stem cells (iPS) derived not from controversial embryonic stem cells, but instead from those of adult mice.
University of Alabama at Birmingham Creates Stem Cell Institute
8/7/2009
Birmingham Business Journal - Jimmy DeButts reports in article entitled “UAB to Bring Jobs, Research through Stem Cell Institute.” The University of Alabama at Birmingham is building on the success of its existing biotech research facilities to create a Stem Cell Institute.
Researchers Believe Adult Stem Cells May be Useful for Wounds
8/4/2009
Paula Moyer reports for Dermatology Times that researchers believe adult stem cells may have a greater role in wound healing in the future. William J. Landis, Ph.D., at the Northeastern Ohio Universities Colleges of Medicine and Pharmacy says that he and his co-workers have been conducting tissue-engineering research with bovine models to learn if stem cells can heal wounds in bones, cartilage and tendons. "Dermatologists should know that investigators are exploring the possibility of promoting wound healing with stem cell treatments,” he said. "Serious cutaneous and connective tissue pathologies should be treatable with stem cells. This is an area of medicine that has broad potential, and I would encourage dermatologists to be involved in the research investigating stem cell use for wound healing in as wide a spectrum of applications as possible," Dr. Landis said. Dr. Landis reports that stem cells may be readily available from a variety of sources, including cord blood and bone
Umbilical Cords a Rich Source of Stem Cells
8/4/2009
Tom Blackwell of the National Post reports that Toronto-based researchers have found that usually discarded umbilical cords are a plentiful source of mesenchymal stem cells. A group of researchers at Princess Margaret Hospital and the University of Toronto in Ontario say they’ve discovered that umbilical cords are a “virtually inexhaustible” and non-controversial source of promising stem cells.
Stem Cells for the Treatment of Type I Diabetes
8/1/2009
Stem cell treatments are gaining momentum as a viable option for successfully slowing down -- or potentially halting -- the progression of type 1 diabetes.
University of Florida Scientists Program Adult Stem Cells to Become Vision Cells
7/30/2009
The University of Florida’s John Pastor reports that researchers at the university have programmed bone marrow stem cells to repair damaged retinas in mice. This suggests that there is potential to treat common causes of vision loss in humans, such as macular degeneration, which affects nearly 2 million people in the United States, and some forms of blindness related to diabetes. Researchers removed blood stem cells from the bone marrow of mice, modified the cells in cultures, and injected them back into the animals’ circulatory systems. From there, the stem cells were able to hone in on the eye injury and become retinal cells. At 28 days after receiving the modified stem cells, mice that had previously demonstrated no retinal function were no different than normal mice in electrical measures of their response to light. The University of Florida’s College of Medicine reports that the success in repairing a damaged layer of retinal cells in mice implies that blood stem cells take
CWRU Receives 5 Million Dollars from Ohio Third Frontier Commission
7/28/2009
Medical News Today reports that the Center for Stem Cell & Regenerative Medicine has received $5 million in funding from Ohio’s Third Frontier Commission under the Research Commercialization Program. The Ohio Third Frontier is a bipartisan organization whose aim is to promote the state’s technological strengths and help with commercialization of technologies. The funding will help support new and innovative stem cell technologies including two commercial, four emerging and three pilot projects. This funding will be matched by each of the projects to create a $10 million grant benefiting stem cell and regenerative medicine in Ohio. The Center for Stem Cell & Regenerative Medicine (CSCRM) is comprised of Case Western Reserve University (CWRU), Cleveland Clinic (CC), University Hospitals (UH), and Athersys, Inc., a clinical stage biopharmaceutical company. "This funding provides CSCRM the support it needs to continue to aggressively move new technologies from academic
UConn Professor’s Stem Cell Research May Lead to Improved Heart Attack Recovery
7/28/2009
Promising research which may potentially improve a person’s recovery after suffering a heart attack.
Johns Hopkins Students Embed Stem Cells In Sutures To Enhance Healing
7/28/2009
ScienceDaily reports that biomedical engineering students at Johns Hopkins University have demonstrated a way to embed a patient's own adult stem cells in the surgical thread that doctors use to repair serious orthopedic injuries such as ruptured tendons. The goal, the students said, is to enhance healing and reduce the likelihood of re-injury without changing the surgical procedure itself. At the site of the injury, the stem cells are expected to reduce inflammation and release growth factor proteins that speed up healing, enhancing the prospects for a full recovery and reducing the likelihood of re-injury. In collaboration with orthopedic physicians, the team's preliminary experiments in an animal model have yielded promising results. Provided the trials continue to be successful, it is estimated that possible human trials could take place within about five years. “We believe the stem cells will significantly speed up and improve the healing process,” said Ma
Study at University of Wisconsin Uses a Stem Cell Treatment for Type 1 Diabetes
7/24/2009
Study aims to learn whether treating newly diagnosed Type 1 diabetics with adult stem cells can either slow or stop the progression of their disease, thereby reducing or even eliminating insulin dependence.
Louisville Man is World’s First Cardiac Stem Cell Recipient
7/24/2009
Laura Ungar of the Louisville Courier-Journal reports on one of the world’s first recipients of an infusion of cardiac stem cells as a part of a Phase 1 clinical trial being conducted by a team of University of Louisville physicians at Jewish Hospital.
Stem Cell Treatments Effective for Secondary Leukemia in Breast Cancer Survivors
7/16/2009
Researchers from the City of Hope National Medical Center have reported on a study that suggests that there continues to be improvement in the results of stem cell treatments for patients with secondary leukemia and myelodysplasia.
Novel Stem Cell Trial Targets Heart Disease
7/10/2009
The Reporter’s Kathy Whitney reports that Vanderbilt Heart and Vascular Institute recently enrolled its first patient in a Phase II clinical trial using stem cell treatments aimed to reverse damage to the patient's cardiac muscle caused by heart disease.
Stem Cell Industry Expert Praises, Encourages Continued Progress on Legislation to Promote Benefits of Cord Blood
7/6/2009
CEO praises legislative progress to date and encouraging continued momentum for existing bills through the second half of the year.
U.S. Doctors Treat Heart Attack With Man's Own Stem Cells
6/30/2009
Forbes.com reports that American physicians have performed the first procedure in which a patient received injections of his own heart stem cells to repair cardiac muscle damaged by heart attack.
Eastern Virginia Medical School Studies Stem Cell Treatments for Diabetes
6/12/2009
Eastern Virginia Medical School (EVMS) is conducting this double blind study on the effectiveness of a new therapy using adult stem cells to treat type 1 diabetes.
How Does One Mend A Broken Heart?
6/5/2009
Current research indicates that it may be possible to “fix a broken heart.” Adult stem cells may be used to help replace damaged heart muscles, heart tissue, valves and establish new blood vessels to supply them.
Ohio House of Representatives Passes Umbilical Cord Blood Bill
6/3/2009
Dayton Ohio Daily News reports that the state’s house unanimously voted in favor of the Cord Blood Education Bill. Under this bill, pregnant women in the state of Ohio would be told about the benefits of storing their newborn’s umbilical cord blood.
Stem Cells Used on Stroke Victim – First in U.S. to be treated with own Cells
5/31/2009
The Houston Chronicle reports that doctors from the University of Texas Medical School have launched the nation's first experimental trial to treat stroke patients with their own stem cells. This new treatment is directed at patients who were not able to receive a tissue plasminogen activator or who did not respond to the treatment, which is reported as the only treatment available now for stroke victims. Neurologist and Professor Sean Savitz reported that the trial's first patient was treated on March 25, 2009 and is doing well. "We're just at the beginning, but this could be an exciting new area of therapeutic intervention for stroke," said the doctor, adding, "It could be the next frontier."
Stem Cells Transplanted from Marrow into Heart May Improve Heart's Performance
5/29/2009
Over the past four years, the Reina Sofía hospital in Córdoba, Spain has been conducting clinical trials using stem cells to treat patients who have suffered one or more heart attacks. One trial in particular, completed in 2007, concluded that one type of stem cell therapy showed great promise. The test consisted of 30 patients who had suffered severe myocardial infarction, or an obstruction of a main coronary artery. One third of the patients received standard treatment; the second group was treated with a medication called G-CSF, which makes cells move from the marrow to the blood, thereby reaching the heart. The third group received stem cells from their bone marrow, which were implanted directly into the coronary artery via catheter.
Mary Tyler Moore discusses her support of the Juvenile Diabetes Research Foundation (JDRF)
5/28/2009
Courtney Ann Jackson of Talk Radio News Service reports on actress Mary Tyler Moore’s announcement of an upcoming Juvenile Diabetes Research Foundation event.
Adult Bone Marrow Stem Cells Injected Into Skeletal Muscle Can Repair Heart Tissue
5/28/2009
Science Daily reports that researchers at the University at Buffalo have demonstrated that injecting adult bone marrow stem cells into skeletal muscle can repair cardiac tissue and reverse heart failure. The study, performed on an animal, showed that this non-invasive procedure increased the number of heart cells two-fold and reduced cardiac tissue injury by 60 percent. It also showed an improved function of the left ventricle, the heart’s primary pumping chamber, by 40%, and reduced fibrosis, the hardening of the heart lining that impairs its ability to contract, by 50%. The novel method of delivering mesenchymal stem cells (MSCs) via an intramuscular route is preferable over clinical trials which have focused more often on invasive procedures such as introducing stem cells directly into the heart. These methods carry more risks and can result in harmful scar tissue, arrhythmia, calcification or small vessel blockages. "For these reasons, and because patients with heart failure
Stem Cell Research Seeks to Wean Non-related Transplant Recipients from Anti-rejection Drugs
5/28/2009
Phase I trial investigating the potential use of stem cells to help reduce or eliminate kidney transplant patients’ reliance on anti-rejection medications
Tuesday, August 24, 2010
Therapeutic Advantages of Cord Blood
Giving your patients every advantage.
This is an exciting, overwhelming time for the expectant parents you serve. Ensure they don’t overlook the value of preserving their newborns’ stem cells, by providing them with the necessary tools to make the right decision for their families.
Why shouldn’t my patients discard their newborn’s umbilical cord blood at birth?
Relating to the disposition of their newborn’s umbilical cord blood, all expectant parents generally have the option to:
- Preserve as a potential autologous (self) benefit for the newborn, and possibly for the newborn's sibling(s) and other family members
- Donate for use by an unrelated recipient, for allogeneic transplants or for research
- Discard at birth as medical waste
Many will certainly come to you for advice. Since your counsel could impact the potential saving of a life, you should consider all of the following vital information before you respond to their queries:
- Medical researchers have discovered umbilical/placental cord blood is rich in stem cells
- Stem cells produce other blood cells and can rebuild the immune system
- Cord blood stem cells have been successfully transplanted and used to treat a number of diseases
Every month, hundreds of OB/GYN's are joining their peers in advising their patients to not discard their baby's umbilical cord blood at birth—one day potentially saving a life.
Why should my patients preserve their newborn’s umbilical cord blood stem cells?
Fifty-nine percent of all pregnant women already have one or more children in their family. Transplanters have shown that cord blood transplants between siblings have a greater chance for engraftment than bone marrow transplants between unrelated donors and recipients. Moreover, there is less chance for graft-vs-host disease following a transplant. Therefore, mothers in this category should seriously consider preserving umbilical cord blood stem cells for their families first.
Also, since the patients own the preserved U-Cord® specimen, there is no charge for retrieval if needed (public banks can charge $15,000 to $25,000 or more for providing a match). Umbilical cord blood stem cells preserved at Cryo-Cell International, Inc., is immediately available if needed. And, parents using a stored specimen reserved for their family would not deplete the public banks' inventory—which means sample is saved to treat another patient. What’s more, preserved umbilical cord blood enables first-time mothers and families to potentially take advantage of evolving stem cell technology.
Can you state any clinical experience with cord blood transplantation?
- First reported transplant: In 1988, for a child with Fanconi's anemia (sibling was the source)
- Study: 85 percent of 44 patients receiving cells from a sibling had engraftment
- Study: 15 of 20 patients had engraftment after receiving placental blood from unrelated donors, even with HLA mismatches
- Study: 562 recipients of placental blood confirmed engraftment was achieved in patients who received an adequate dose of nucleated cells
- Decreased risk of both chronic and acute graft-vs-host disease, especially when donor and recipient are related
Can a transplant story illustrate the case for preserving umbilical cord stem cells?
February 1, 2003
A three-year-old boy diagnosed with T-cell lymphoma was treated with a cord blood stem cell transplant using cryopreserved hematopoietic stem cells from a younger sibling. The transplant was indicated after the patient failed to respond to standard chemotherapy. The donor was a perfect HLA match, and engraftment occurred at day 13 post-transplant. The patient remains in remission, 4+ years after transplant.
The cord blood was collected approximately two months prior to the transplant, at the birth of the patient's sibling. The 145 ml of cord blood collected contained 5.306 million of the CD 34+ cells that are essential for successful engraftment. The cord blood was processed by Cryo-Cell. A density gradient separation process was used to remove the red blood cells and plasma, isolating the mononuclear white blood cells. These cells were then mixed with DMSO, the cryoprotectant, and stored in cryovials with autologous plasma and media in Cryo-Cell’s cryogenic storage facility. HLA testing was conducted and determined that the two male siblings were an identical match. The blood was stored until the patient's health status was stable enough to proceed with the transplant.
The transplant procedure was performed at All Children's Hospital, St. Petersburg, Florida. In order to ablate the bone marrow in preparation for the transplant, the patient underwent three days of Total Body Irradiation (TBI) followed by two days of high-dose cyclophosphamide chemotherapy. After one day of rest, the patient received his cord blood infusion.
The patient remains in remission. All post-transplant testing has determined that the child's engraftment status is 100 percent donor origin, with all blood components of his hematopoietic system being ‘grown’ from his new bone marrow.
The use of cord blood stem cells is an accepted clinical therapy for the treatment of leukemia, lymphomas and other life-threatening diseases. This use of cord blood for the treatment of hematological malignancies was pioneered in the early 1990s. Stem cells derived from cord blood have been shown to have certain advantages over bone marrow including less need for stringent HLA matching and less severe graft-versus-host disease.
This transplant case summary was prepared with information supplied by a Transplant Coordinator at All Children's Hospital and Cryo-Cell, and with the consent of the patient's family.
Subscribe to:
Comments (Atom)